Bionpharma Inc. FDA Inspection Record
Bionpharma Inc. is an FDA-inspected facility (FEI 3011705836) located in Princeton, NJ, US. RegDataLab tracks 2 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Sep 19, 2024: No Action Indicated (NAI)
- Inspections on record
- 2 (2 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 4, latest Aug 7, 2026
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Sep 19, 2024 | No Action Indicated (NAI) | No citations listed |
| Jun 26, 2017 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Aug 7, 2026 | Class III | D-0822-2026 | Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count… Presence of Foreign Tablets/Capsules |
| Jun 26, 2026 | Class II | D-0742-2026 | Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only… Presence of Foreign Tablets/Capsules |
| Sep 17, 2024 | Class I | D-0012-2025 | Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by… Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria. |
| Jul 16, 2019 | Class II | D-1519-2019 | Clobazam Oral Suspension, 2.5 mg/mL, 120 mL bottle, Rx only, Distributed by: Bionpharma… Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed. |
FDA record score
14 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
3 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class I recall D-0012-2025, this FEI as the recalling firm | Sep 17, 2024 | 15 x 0.6 | 9 |
| Class II recall D-0742-2026, this FEI as the recalling firm | Jun 26, 2026 | 4 x 1 | 4 |
| Class II recall D-1519-2019, this FEI as the recalling firm | Jul 16, 2019 | 4 x 0.25 | 1 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Bionpharma Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Bionpharma Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Bionpharma Inc.
- Location
- Princeton, NJ (US)
- Source
- inspections